Dynavax Total Assets from 2010 to 2025

DVAX Stock

USD 12.45 0.06 0.48%

Dynavax Technologies Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2001-12-31

Previous Quarter

1 B

Current Value

1.1 B

Quarterly Volatility

319.9 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 M, Interest Expense of 4 M or Other Operating Expenses of 325.2 M, as well as many indicators such as Price To Sales Ratio of 6.62, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.

Check out the analysis of Dynavax Technologies Correlation against competitors.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Total Assets Growth Pattern

Below is the plot of the Total Assets of Dynavax Technologies over the last few years. Total assets refers to the total amount of Dynavax Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dynavax Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Dynavax Technologies' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 997.1 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Dynavax Total Assets Regression Statistics

	Arithmetic Mean	462,970,239
	Geometric Mean	289,181,951
	Coefficient Of Variation	93.89
	Mean Deviation	382,249,328
	Median	218,785,000
	Standard Deviation	434,700,083
	Sample Variance	188964.2T
	Range	1.2B
	R-Value	0.88
	Mean Square Error	45134.1T
	R-Squared	0.78
	Slope	80,487,201
	Total Sum of Squares	2834462.4T

Dynavax Total Assets History

	2025	1.2 B
	2024	1.1 B
	2023	997.1 M
	2022	985.9 M
	2021	1 B
	2020	353.3 M
	2019	279.1 M

Other Fundumenentals of Dynavax Technologies

Intangibles To Total Assets

Dynavax Technologies Total Assets component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.89	-0.44	0.86	0.23	0.86	0.24	0.89	0.55	0.24	0.98	0.79	-0.66	-0.11	0.9	-0.29	0.88	0.79	0.78	0.82	-0.61	0.94	0.92	0.93
Total Stockholder Equity	0.89		-0.19	0.55	0.17	0.97	0.26	0.63	0.19	0.31	0.95	0.57	-0.64	-0.16	0.7	-0.15	0.99	0.63	0.57	0.64	-0.69	0.97	0.96	0.79
Retained Earnings	-0.44	-0.19		-0.61	-0.65	-0.23	0.01	-0.73	-0.39	-0.35	-0.36	-0.41	0.44	-0.09	-0.64	0.7	-0.11	-0.79	-0.72	-0.77	0.08	-0.23	-0.22	-0.51
Total Liab	0.86	0.55	-0.61		0.24	0.51	0.15	0.96	0.82	0.1	0.76	0.84	-0.52	-0.02	0.89	-0.37	0.53	0.76	0.82	0.82	-0.36	0.66	0.65	0.86
Accounts Payable	0.23	0.17	-0.65	0.24		0.28	-0.02	0.41	-0.08	0.57	0.25	0.01	-0.47	0.13	0.46	-0.42	0.1	0.61	0.54	0.6	-0.08	0.19	0.2	0.31
Short Term Investments	0.86	0.97	-0.23	0.51	0.28		0.25	0.61	0.08	0.49	0.94	0.44	-0.64	-0.11	0.74	-0.14	0.96	0.63	0.63	0.64	-0.75	0.96	0.96	0.78
Common Stock	0.24	0.26	0.01	0.15	-0.02	0.25		0.14	0.16	0.04	0.24	0.2	0.38	-0.18	0.14	0.5	0.25	0.11	0.1	0.04	-0.02	0.19	0.18	0.24
Property Plant Equipment	0.89	0.63	-0.73	0.96	0.41	0.61	0.14		0.72	0.21	0.81	0.78	-0.64	-0.1	0.91	-0.48	0.59	0.86	0.85	0.91	-0.44	0.71	0.7	0.88
Current Deferred Revenue	0.55	0.19	-0.39	0.82	-0.08	0.08	0.16	0.72		-0.43	0.4	0.72	-0.16	-0.11	0.47	-0.23	0.18	0.44	0.4	0.48	-0.01	0.26	0.27	0.52
Net Debt	0.24	0.31	-0.35	0.1	0.57	0.49	0.04	0.21	-0.43		0.33	-0.08	-0.32	0.12	0.53	-0.13	0.29	0.42	0.58	0.42	-0.37	0.38	0.37	0.4
Total Current Assets	0.98	0.95	-0.36	0.76	0.25	0.94	0.24	0.81	0.4	0.33		0.66	-0.68	-0.1	0.86	-0.23	0.94	0.74	0.74	0.77	-0.7	0.98	0.98	0.9
Net Receivables	0.79	0.57	-0.41	0.84	0.01	0.44	0.2	0.78	0.72	-0.08	0.66		-0.42	-0.12	0.71	-0.26	0.58	0.64	0.61	0.69	-0.18	0.63	0.54	0.76
Good Will	-0.66	-0.64	0.44	-0.52	-0.47	-0.64	0.38	-0.64	-0.16	-0.32	-0.68	-0.42		-0.03	-0.65	0.53	-0.6	-0.62	-0.6	-0.72	0.61	-0.69	-0.68	-0.59
Intangible Assets	-0.11	-0.16	-0.09	-0.02	0.13	-0.11	-0.18	-0.1	-0.11	0.12	-0.1	-0.12	-0.03		0.06	-0.09	-0.17	0.01	0.28	-0.06	0.0	-0.12	-0.12	-0.15
Long Term Debt	0.9	0.7	-0.64	0.89	0.46	0.74	0.14	0.91	0.47	0.53	0.86	0.71	-0.65	0.06		-0.39	0.67	0.86	0.96	0.9	-0.53	0.81	0.79	0.93
Short Term Debt	-0.29	-0.15	0.7	-0.37	-0.42	-0.14	0.5	-0.48	-0.23	-0.13	-0.23	-0.26	0.53	-0.09	-0.39		-0.1	-0.61	-0.42	-0.57	0.06	-0.17	-0.15	-0.31
Net Tangible Assets	0.88	0.99	-0.11	0.53	0.1	0.96	0.25	0.59	0.18	0.29	0.94	0.58	-0.6	-0.17	0.67	-0.1		0.58	0.53	0.59	-0.68	0.97	0.95	0.77
Capital Surpluse	0.79	0.63	-0.79	0.76	0.61	0.63	0.11	0.86	0.44	0.42	0.74	0.64	-0.62	0.01	0.86	-0.61	0.58		0.84	0.97	-0.26	0.67	0.64	0.86
Deferred Long Term Liab	0.78	0.57	-0.72	0.82	0.54	0.63	0.1	0.85	0.4	0.58	0.74	0.61	-0.6	0.28	0.96	-0.42	0.53	0.84		0.86	-0.45	0.68	0.66	0.83
Long Term Debt Total	0.82	0.64	-0.77	0.82	0.6	0.64	0.04	0.91	0.48	0.42	0.77	0.69	-0.72	-0.06	0.9	-0.57	0.59	0.97	0.86		-0.32	0.7	0.68	0.89
Short Long Term Debt	-0.61	-0.69	0.08	-0.36	-0.08	-0.75	-0.02	-0.44	-0.01	-0.37	-0.7	-0.18	0.61	0.0	-0.53	0.06	-0.68	-0.26	-0.45	-0.32		-0.71	-0.76	-0.46
Net Invested Capital	0.94	0.97	-0.23	0.66	0.19	0.96	0.19	0.71	0.26	0.38	0.98	0.63	-0.69	-0.12	0.81	-0.17	0.97	0.67	0.68	0.7	-0.71		0.98	0.87
Net Working Capital	0.92	0.96	-0.22	0.65	0.2	0.96	0.18	0.7	0.27	0.37	0.98	0.54	-0.68	-0.12	0.79	-0.15	0.95	0.64	0.66	0.68	-0.76	0.98		0.85
Capital Stock	0.93	0.79	-0.51	0.86	0.31	0.78	0.24	0.88	0.52	0.4	0.9	0.76	-0.59	-0.15	0.93	-0.31	0.77	0.86	0.83	0.89	-0.46	0.87	0.85

Click cells to compare fundamentals

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	1.1 B	1.2 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC